Posts Categorized: MS News

Remyelination in MS – what progress has been made?

Source MS Trust: A recent review has outlined the progress made so far in understanding the biology of remyelination, what goes wrong in MS, some of the research problems that need to be tackled and the prospect for treatments in the not-too-distant future. Considerable progress has been made in understanding the biology of remyelination. This has… Read more »

Call for national neurology plan following largest ever survey of people with neurological conditions

Source MS Trust: People with neurological conditions are facing long waiting times, limited access to specialists, poor mental health support and a failing social care system, according to a new survey by The Neurological Alliance. The National Neurology Patient Experience Survey presents a picture of the experiences of people living with a neurological condition in England. … Read more »

Standing frame intervention improves life for people with multiple sclerosis, research shows

Source Medical Xpress: A new study has shown that people in the advanced stage of multiple sclerosis (MS) experience significant improvements in movement and balance thanks to a specialised standing frame. Led by the University of Plymouth and published today in The Lancet Neurology, the study in people with progressive MS also showed that the intervention appeared… Read more »

Top tips for a stress-free summer holiday

Source MS Trust: Finding the right holiday for you. It’s that time of year when everyone is jetting off on holiday, but when you have MS there’s often a bit more planning involved before you can pack up your suitcase and head to the beach. Where can you find accessible accommodation and attractions? How do you… Read more »

Nanotechnology treatment shows promise against multiple sclerosis

Source m.phys.org: A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by the University of California, Irvine researchers. “Until now, stem cell therapies for autoimmune and neurodegenerative diseases have produced mixed results in clinical trials, partly because… Read more »

Scientists edge closer to root causes of multiple sclerosis

Source Science Daily: Researchers have found mutations in 12 genes believed to be largely responsible for the onset of multiple sclerosis in families with multiple members diagnosed with the disease. An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative… Read more »

Recommended by one of our members – Pharmacy2U

We take care of your NHS Repeat Prescriptions. With easy online ordering, free flexible delivery and reminders to re-order. Get your NHS repeat prescriptions delivered FREE to your door. We arrange and deliver your NHS repeat prescriptions to your door – for free. The Electronic Prescription Service is an NHS service which allows you to… Read more »

Researchers devise AI-based method of detecting response to MS

Source UCLH.nhs.uk: UCLH’s Biomedical Research Centre has supported the development of a new artificial intelligence-based method for detecting the brain’s response to treatment in multiple sclerosis (MS) that is substantially better than what a human expert is able to do using conventional techniques, representing potentially ‘superhuman’ performance in the task. UCL researchers – led by Dr… Read more »

Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS

Source MS Trust: The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS. NICE has approved Ocrevus for people with primary progressive MS if they: have had symptoms of primary progressive MS for 15 years or less and are able to walk 20 metres or more, with or without walking aids (up… Read more »

Multiple Sclerosis News Today Daily Digest

Worth reading, the Ocrelizumab (Ocrevus) story, plus second and third items.  But a warning to all, not all the comments are positive. Multiple Sclerosis News Today The Web’s Daily Resource for Multiple Sclerosis News In the 05/13/2019 edition: MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy,… Read more »